Lanthanum carbonate and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Lanthanum carbonate and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanthanum carbonate
Brand name: Fosrenol
Synonyms: Lanthanum
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanthanum carbonate-Moxifloxacin
- Lanthanum carbonate-Moxifloxacin (Systemic)
- Lanthanum carbonate-Moxifloxacin Hydrochloride
- Lanthanum carbonate-Moxifloxacin Injection
- Lanthanum carbonate-Moxifloxacin Intravenous
- Lanthanum carbonate-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Lanthanum Carbonate Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Lanthanum Chewable Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Lanthanum Powder
- Moxetumomab pasudotox-tdfk Intravenous-Lantus
- Moxetumomab pasudotox-tdfk Intravenous-Lantus SoloStar
- Moxetumomab pasudotox-tdfk Intravenous-Lantus SoloStar (Insulin Glargine (U-100) Cartridge Systems and Pens)